We believe that DNA testing can empower healthcare professionals and their patients. We understand the concerns that surround inherited genetic illness, cancer and serious health conditions and work to mitigate the risks and develop more targeted solutions. Our genetic screening and advisory services apply the latest technology and data analysis to support doctors and specialists providing effective treatments and the best available preventive, predictive and personalized medicine.
Based in Hong Kong, our unique capabilities in research and development, product development and testing ensure that we’re always at the forefront of our industry’s technological advances.
Through innovation, technology and expertise, we’re a step ahead for healthcare.
Molecular diagnostics technology moves fast. Newer tests tend to be quicker, more revealing and more expensive. Older tests often cost less but may not be as informative. There is a valuable role for both. Our goal is to give medical professionals and patients the widest possible choice. Our technology includes cutting edge next-generation sequencing (NGS) and other frequently used methods such as RT-PCR and Sanger sequencing.
United by their shared ambition to help advance genetic testing technology, our team are experts in their fields and are driven to share technology, knowledge and data that benefits healthcare.
Scientific Advisory Board
Dr. Sherman Zheng
Dr. Zheng was a medical doctor in China’s Chang Chun Hospital for 10 years. He then worked as a Senior Scientist at UBI in New York before accepting a position at New York University.
Prof. Yuk-Lam Lo
With an outstanding career that spans science, business and innovation, Professor Lo is widely considered the “Father of Biotechnology” in Hong Kong.
Dr. See-Ying Tam
Currently Principal Investigator with the Department of Pathology, Dr. Tam joined Stanford University in 1999. He is also an Honorary Associate Professor at The University of Hong Kong.
Dr. Christopher Corless — Consulting Specialist
Partner lab – Knight Diagnostic Laboratories
To complement our in-house expertise, we work closely with KDL to bring oncologists a wide selection of tests. US-based KDL is a global leader in developing genetic tests for solid tumors and hematopoietic malignancies.
College of American Pathologists (CAP) accreditation – Pathology & MP
Clinical Laboratory Improvement Act (CLIA) by the Centers of Medicare and Medicaid Services (CMS) – Pathology